{"id":"NCT02692716","sponsor":"Novo Nordisk A/S","briefTitle":"A Trial Investigating the Cardiovascular Safety of Oral Semaglutide in Subjects With Type 2 Diabetes","officialTitle":"A Trial Investigating the Cardiovascular Safety of Oral Semaglutide in Subjects With Type 2 Diabetes","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2017-01-17","primaryCompletion":"2018-09-25","completion":"2018-09-25","firstPosted":"2016-02-26","resultsPosted":"2020-02-27","lastUpdate":"2022-07-20"},"enrollment":3183,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Diabetes","Diabetes Mellitus, Type 2"],"interventions":[{"type":"DRUG","name":"semaglutide","otherNames":[]},{"type":"DRUG","name":"placebo","otherNames":[]}],"arms":[{"label":"Oral semaglutide","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"This trial is conducted globally. The aim of the trial is to investigate the cardiovascular safety of oral semaglutide in subjects with type 2 diabetes.","primaryOutcome":{"measure":"Time From Randomisation to First Occurrence of a Major Adverse Cardiovascular Event (MACE) Composite Endpoint Consisting of: Cardiovascular Death, Non-fatal Myocardial Infarction or Non-fatal Stroke","timeFrame":"Maximum treatment duration is dependent on event rates and is estimated to be no longer than 19 months + 5 weeks of follow-up period.","effectByArm":[{"arm":"Oral Semaglutide","deltaMin":61,"sd":null},{"arm":"Placebo","deltaMin":76,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"< 0.0001"},{"comp":"OG000 vs OG001","p":"= 0.1749"}]},"eligibility":{"minAge":"50 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":2,"exclusionCount":9},"locations":{"siteCount":228,"countries":["United States","Algeria","Argentina","Brazil","Canada","Denmark","Germany","India","Israel","Italy","Malaysia","Mexico","Netherlands","Poland","Romania","South Africa","Spain","Taiwan","Thailand","Turkey (TÃ¼rkiye)","United Kingdom"]},"refs":{"pmids":["29263194","30284349","31185157","34277983","35484580","35373893","39963952","39520501","37620807","35582947","33606902","32998732","32267058","31903692"],"seeAlso":["http://novonordisk-trials.com"]},"adverseEventsSummary":{"seriousAny":{"events":301,"n":1591},"commonTop":[]}}